This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Atrialfibrillation (AF) is associated with the development of dementia and observational studies have shown that oral anticoagulation (OAC) and catheter ablation reduce dementia risk.
Catheter ablation (CA) of atrialfibrillation (AF) has been proved to benefit patient with symptomatic AF and heart failure. However, the data on neurological outcomes including cerebrovascular disease (CVA) and dementia remain a controversy.
ABSTRACTAtrial fibrillation (AF) is the most common cardiac arrhythmia. AF increases the risk of stroke, heart failure, dementia, and hospitalization. Weight loss has been shown to reverse these changes and reduce AF risk and recurrence after ablation. Journal of the American Heart Association, Ahead of Print.
AF stands for atrialfibrillation. There was a study in 2009 called the Intermountain Heart collaborative study which evaluated 37000 patients and followed them for development of AF and dementia and found that patients with AF were 44% more likely to develop dementia compared to patients without AF.
The American College of Cardiology (ACC) and the American Heart Association (AHA) recently published new guidelines for the diagnosis and management of patients with atrialfibrillation (AF). By 2030, it is estimated that AF prevalence in the United States will rise to 12.1 million.
Background:Catheter ablation (CA) is increasingly used for treatment of atrialfibrillation (AF). years; 55% female, 28% frailty, 13% dementia), including 8% receiving CA. Circulation, Volume 150, Issue Suppl_1 , Page A4141439-A4141439, November 12, 2024. The mean follow-up was 1.8 per 100 person-years; HR:0.72, 95%CI:0.66-0.77)
Atrialfibrillation (AF) is the most frequent heart rhythm disorder worldwide with a prevalence of 1%2% in general population. It is associated with increased mortality and morbidity, including increased risk of dementia. In addition to cognitive impairment, AF has been related to anxiety and mood disorders.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content